Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.74 |
| ▸ | MAPT | P10636 | 5/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | POLB | P06746 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.72 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.72 |
| ▸ | TDP2 | O95551 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | NMT1 | P30419 | 1/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | EGFR | P00533 | 1/20 | 0.65 |
| ▸ | MMP1 | P03956 | 1/20 | 0.65 |
| ▸ | MMP2 | P08253 | 1/20 | 0.65 |
| ▸ | MMP9 | P14780 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30764065 | 1.00 | ALDH1A1 (0.74) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL3224667 | 1.00 | ALDH1A1 (0.74) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL11137034 | 0.90 | LPAR2 (0.88) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL11133691 | 0.90 | LPAR2 (0.88) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL13381223 | 0.84 | LPAR2 (1.00) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL15708801 | 0.83 | ALDH1A1 (0.69) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL13113092 | 0.83 | TGM2 (0.59) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL4738261 | 0.82 | MAPT (1.00) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL5177071 | 0.82 | MAPT (1.00) | ALDH1A1MAPTL3MBTL1KMT2APOLB | |
| SCHEMBL4738270 | 0.82 | MAPT (1.00) | ALDH1A1MAPTL3MBTL1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739279-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | Neomics Co., Ltd. (KR) | 2014-06-11 | — | — | EP | claimed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | claimed |
| WO-2013019093-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) | 2013-02-07 | — | — | WO | claimed |
| JP-2184660-A | — | — | None | — | — | JP | disclosed |
| EP-2739279-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | Neomics Co., Ltd. (KR) | 2014-06-11 | — | — | EP | disclosed |
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | NEOMICS Co, Ltd. (KR) | 2014-05-22 | — | — | US | disclosed |
| WO-2013019093-A2 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MEDICINAL BIOCONVERGENCE RESEARCH CENTER (KR) | 2013-02-07 | — | — | WO | disclosed |
| JP-H02184660-A | PRODUCTION OF N-FLUOROPHENYLMALEAMIC ACID | NIPPON OIL & FATS CO LTD | 1990-07-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142333-A1 | NOVEL ANILINE DERIVATIVES AND USE THEREOF | MCL1, GOT2, DDX21 | ALDH1A1 613/4885MAPT 2433/4885L3MBTL1 1149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.